GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of week 46 check-in — 21kg down, early fullness manageable, one thing confusing me — 8 comments in the full submission. View in context.
-18
c/tirzepatide·submitted 2 years ago by u/halima_boateng

week 46 check-in — 21kg down, early fullness manageable, one thing confusing me

Trial Databranch of 7 comments

Check-in as promised in the title: week 46 check-in — 21kg down, early fullness manageable, one thing confusing me. The relevant figures are week 46 and 21kg, and they come from the same log I have kept the whole time. It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in…

Read the full submission and all 8 comments →

This branch

7 comments, started 2 years ago
u/titration_marshalMOD6 points·2 years ago

Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.

replysharereportpermalink
u/mod_cold_roommod · c/coldchain1 point·2 years ago

Flair corrected to Results, since the body has numbers in it and the title promised them.

replysharereportpermalink
u/dexa_twice_yearlybody comp5 points·2 years ago

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your fatigue pattern is a guess.

replysharereportpermalink
u/incretin_ivypharmacology4 points·2 years ago

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

replysharereportpermalink
u/sanne_novak1 point·2 years ago

Did you come to this from sema, and if so how long was the gap?

replysharereportpermalink
u/priya_guerrero4 points·2 years ago

Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.

replysharereportpermalink
u/nordic_pricing1 point·2 years ago

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.